Perrigo Announces Final FDA Approval and Planned Launch for the Store Brand OTC Equivalent of Mucinex(R) DM Maximum Strength Extended Release Tablets

DUBLIN, March 7, 2018 -- (Healthcare Sales & Marketing Network) -- Perrigo Company plc (NYSE; TASE: PRGO) today announced that it has received final approval from the U.S. Food & Drug administration for the store brand OTC equivalent of Mucinex® DM Ma... Biopharmaceuticals, Generics, FDA, Product Launch Perrigo, Mucinex, Guaifenesin, Dextromethorphan
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news